Debate: Are surrogate end-point studies worth the effort?
Surrogate end-points of cardiovascular disease can provide useful information in cross-sectional, prospective and interventional studies. They provide information on association with risk factors, natural history and factors associated with disease progression. Because every participant can reach an...
保存先:
| 出版年: | Curr Control Trials Cardiovasc Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2000
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59602/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11714413/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-1-2-072 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|